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Identity 
Other names: SYLD; KIAA1248; DKFZp781G1938; 
HGNC 14460 




The gene encompasses 9013 bp of DNA; 16 or 17 
exons (the first and second are non-coding). 
Transcription 
Eight splicing mRNAs are found. 
2142 bp mRNA; CDS: 174-1289bp; 1113 bp open 
reading frame 
2100 bp mRNA; CDS: 174-1247bp; 1071 bp open 
reading frame 
2033 bp mRNA; CDS: 107-1180bp; 1071 bp open 
reading frame 
2075 bp mRNA; CDS: 107-1222bp; 1113 bp open 
reading frame 
2010 bp mRNA; CDS: 84-1157bp; 1071 bp open 
reading frame 
2052 bp mRNA; CDS: 84-1199bp; 1113 bp open 
reading frame 
2119 bp mRNA; CDS: 151-1266bp; 1113 bp open 
reading frame 




357 amino acids; another isoform has 371 amino acids; 
40 or 43 kDa; Thr348 is a Akt phosphorylation site, 
Ser332 is a PKC teta-phosphorylation site. NDRG2 has 
the alpha/beta hydrolase fold motif. 
Expression 
Widely expressed, especially in brain, heart, skeletal 




A candidate tumor suppressor gene. Ndrg2 expressed 
much higher in normal tissues than the tumors (brain, 
liver, pancreas tissues etc). Overexpression of ndrg2 
can inhibit the proliferation of glioblastoma U373 and 
U138 cells. NDRG2 upregulation is associated with 
disease pathogenesis in the human brain. Ndrg2 is 
expressed during the differentiation of DCs, and the
expression is differentially regulated by maturation-
inducing stimuli such as LPS and CD40. The 
expression of ndrg2 in rat frontal cortex was decreased 
by chronic antidepressant treatment. 
Homology 
At the amino acid level, human NDRG2 shows 57% 
identical to NDRG1 and NDRG3, 65% identical to 
NDRG4-B, 63% identical to NDRG4-Bvar and 61% 
identical to NDRG4-H respectively. Also human 




Alzheimer's disease is the most common cause of 
dementia. Dementia is a collective name for 
progressive degenerative brain syndromes, which affect 
memory, thinking, behavior and emotion. Symptoms  
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may include: 1) lose of memory; 2) difficulty in finding 
the right words or understanding what people are 
saying; 3) difficulty in performing previously routine 
tasks; 4) personality and mood changes. 
Prognosis 
The probable outcome is poor. The disorder is usually 
not acute, but progresses steadily. Total disability s 
common. Death normally occurs within 15 years, 
usually from an infection or a failure of other body 
systems. The duration of illness, from onset of 
symptoms to death, averages 8 to 10 years. 
Hybrid/Mutated gene 
NDRG2 is upregulated at both the RNA and protein 
levels in AD brains. Expression of NDRG2 in affected 
brains was revealed in: (1) cortical pyramidal neurons, 
(2) senile plaques and (3) cellular processes of 
dystrophic neurons. NDRG2 upregulation is associated 
with disease pathogenesis in the human brain. 
Liver cancers 
Disease 
Liver cancers are primary liver tumors 
(hepatoma/hepatocellular carcinoma, bile duct 
cancer/cholangio-carcinoma) or metastatic liver tumor. 
Oncogenesis 
Compared with adjacent normal tissues, the expression 
levels of NDRG2 mRNA in liver cancer tissues 
reduced significantly, but the mutation in the whole 
coding region of NDRG2 was not found. 
Glioblastoma 
Disease 
Glioblastoma multiforme (GBM) is the most aggressive 
form of the primary brain tumors known collectively as 
gliomas. These tumors arise from the supporting, glial
cells of the brain during childhood and in adults. These 
growths do not spread throughout the body like other 
forms of cancer, but cause symptoms by invading the 
brain.NDRG2 gene was first found in this tissue by 
using subtraction cloning. 
Oncogenesis 
Ndrg2 is present at low levels in human GBM tissues 
and glioblastoma cell lines comparing with normal 
tissue and cells. Transient transfection exogenous 
NDRG2 gene will inhibits glioblastoma U373 and 
U138 cells proliferation. 
Gastric cancer 
Disease 
Gastric cancer is the result of cell changes in the lining 
of the stomach. The most common types of stomach 
cancer start in the glandular cells of the stomach lining 
and are known as adenocarcinomas. These are rare 
cancers that usually start from the cells of the muscle 
layer of the stomach. The most common type of 
sarcoma to affect the stomach is a leiomyosarcoma. 
Another type of sarcoma is a gastrointestinal stromal 
tumour (GIST). 
Oncogenesis 
Ndrg2 is present at low level in some stomach cancer 
tissue and cell lines. 
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